Correction: Cook et al. An Optimized Bioassay for Screening Combined Anticoronaviral Compounds for Efficacy against Feline Infectious Peritonitis Virus with Pharmacokinetic Analyses of GS-441524, Remdesivir, and Molnupiravir in Cats. Viruses 2022, 14, 2429. [PDF]
Cook S +10 more
europepmc +1 more source
Generating and evaluating type I interferon receptor-deficient and feline TMPRSS2-expressing cells for propagating serotype I feline infectious peritonitis virus. [PDF]
Mettelman RC +3 more
europepmc +1 more source
Transcriptome analysis of feline infectious peritonitis virus infection. [PDF]
Mehrbod P, Harun MS, Shuid AN, Omar AR.
europepmc +1 more source
Characterizing replication kinetics and plaque production of type I feline infectious peritonitis virus in three feline cell lines. [PDF]
O'Brien A +5 more
europepmc +1 more source
PD-L1 expression in tissues of cats with naturally occurring feline infectious peritonitis. [PDF]
Zabiegala A, Kim Y, Long M, Chang KO.
europepmc +1 more source
Outcomes of a 42-day course of molnupiravir in cats with feline infectious peritonitis: a prospective descriptive study. [PDF]
Hishinuma K +3 more
europepmc +1 more source
The value of serum exosomal miRNA signature profiles for the early diagnosis of feline infectious peritonitis. [PDF]
Gu H, Wu H.
europepmc +1 more source
Current Status on Treatment Options for Feline Infectious Peritonitis and SARS-CoV-2 Positive Cats
Feline infectious peritonitis (FIP) is a viral-induced, immune-mediated disease of cats caused by virulent biotypes of feline coronaviruses (FCoV), known as the feline infectious peritonitis virus (FIPV).
Jacqueline M. Norris, Merran Govendir
exaly +2 more sources

